43
|
212
|
8cbdF |
Sars-cov-2 delta-rbd complexed with ba.4/5-1 and ey6a fabs |
37
|
220
|
8cbdA |
Sars-cov-2 delta-rbd complexed with ba.4/5-1 and ey6a fabs |
44
|
213
|
8cbdB |
Sars-cov-2 delta-rbd complexed with ba.4/5-1 and ey6a fabs |
43
|
194
|
8cbdR |
Sars-cov-2 delta-rbd complexed with ba.4/5-1 and ey6a fabs |
41
|
219
|
8cbfA |
Sars-cov-2 delta-rbd complexed with omi-42 and beta-49 fabs |
49
|
216
|
8cbfB |
Sars-cov-2 delta-rbd complexed with omi-42 and beta-49 fabs |
48
|
226
|
8cbfH |
Sars-cov-2 delta-rbd complexed with omi-42 and beta-49 fabs |
39
|
198
|
8cbfE |
Sars-cov-2 delta-rbd complexed with omi-42 and beta-49 fabs |
45
|
212
|
8cbfL |
Sars-cov-2 delta-rbd complexed with omi-42 and beta-49 fabs |
33
|
143
|
8k3kD |
The crystal structure of nanobody nb4 in complex with receptor binding domain (rbd) of ba.1 spike protein |
38
|
194
|
8k3kE |
The crystal structure of nanobody nb4 in complex with receptor binding domain (rbd) of ba.1 spike protein |
43
|
219
|
8fhyC |
Crystal structure of the sars-cov-2 receptor binding domain in complex with neutralizing antibody wrair-5021 |
42
|
198
|
8fi9A |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody wrair-5001 |
47
|
214
|
8fhyB |
Crystal structure of the sars-cov-2 receptor binding domain in complex with neutralizing antibody wrair-5021 |
41
|
199
|
8fhyA |
Crystal structure of the sars-cov-2 receptor binding domain in complex with neutralizing antibody wrair-5021 |
41
|
211
|
8fi9F |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody wrair-5001 |
28
|
221
|
8fi9G |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody wrair-5001 |
49
|
214
|
7y3nD |
Crystal structure of sars-cov receptor binding domain in complex with human antibody biols56 |
42
|
227
|
7y3nC |
Crystal structure of sars-cov receptor binding domain in complex with human antibody biols56 |
35
|
196
|
7y3nA |
Crystal structure of sars-cov receptor binding domain in complex with human antibody biols56 |
36
|
188
|
8q7sA |
Crystal structure of the sars-cov-2 rbd (wuhan) with neutralizing vhhs ma6f06 and re21h01 |
38
|
194
|
8q93A |
Crystal structure of the sars-cov-2 rbd with neutralizing-vhhs re30h02 and re21d01 |
33
|
182
|
8q94A |
Crystal structure of the sars-cov-2 ba.2.75 rbd with neutralizing-vhhs re32d03 and ma3b12 |
38
|
127
|
8q95B |
Crystal structure of the sars-cov-2 ba.1 rbd with neutralizing-vhhs ma16b06 and ma3f05 |
35
|
216
|
8hq7N |
Cryo-em structure of sars-cov-2 omicron prototype rbd in complex with fab l4.65 and l5.34 |
46
|
213
|
8hrdE |
Crystal structure of the receptor binding domain of sars-cov-2 delta variant in complex with imcas74 fab and w14 fab |
47
|
229
|
8hrdD |
Crystal structure of the receptor binding domain of sars-cov-2 delta variant in complex with imcas74 fab and w14 fab |
44
|
215
|
8hrdF |
Crystal structure of the receptor binding domain of sars-cov-2 delta variant in complex with imcas74 fab and w14 fab |
44
|
230
|
8hrdC |
Crystal structure of the receptor binding domain of sars-cov-2 delta variant in complex with imcas74 fab and w14 fab |
27
|
114
|
8q93B |
Crystal structure of the sars-cov-2 rbd with neutralizing-vhhs re30h02 and re21d01 |
32
|
231
|
8hq7H |
Cryo-em structure of sars-cov-2 omicron prototype rbd in complex with fab l4.65 and l5.34 |
31
|
195
|
8hq7A |
Cryo-em structure of sars-cov-2 omicron prototype rbd in complex with fab l4.65 and l5.34 |
36
|
215
|
8hq7L |
Cryo-em structure of sars-cov-2 omicron prototype rbd in complex with fab l4.65 and l5.34 |
25
|
116
|
8q7sB |
Crystal structure of the sars-cov-2 rbd (wuhan) with neutralizing vhhs ma6f06 and re21h01 |
29
|
116
|
8q95C |
Crystal structure of the sars-cov-2 ba.1 rbd with neutralizing-vhhs ma16b06 and ma3f05 |
31
|
128
|
8q94B |
Crystal structure of the sars-cov-2 ba.2.75 rbd with neutralizing-vhhs re32d03 and ma3b12 |
40
|
195
|
8hrdA |
Crystal structure of the receptor binding domain of sars-cov-2 delta variant in complex with imcas74 fab and w14 fab |
44
|
184
|
8q95A |
Crystal structure of the sars-cov-2 ba.1 rbd with neutralizing-vhhs ma16b06 and ma3f05 |
26
|
130
|
8q93C |
Crystal structure of the sars-cov-2 rbd with neutralizing-vhhs re30h02 and re21d01 |
24
|
126
|
8q7sC |
Crystal structure of the sars-cov-2 rbd (wuhan) with neutralizing vhhs ma6f06 and re21h01 |
27
|
127
|
8q94C |
Crystal structure of the sars-cov-2 ba.2.75 rbd with neutralizing-vhhs re32d03 and ma3b12 |
41
|
225
|
8hq7M |
Cryo-em structure of sars-cov-2 omicron prototype rbd in complex with fab l4.65 and l5.34 |
37
|
215
|
6zdgC |
Association of three complexes of largely structurally disordered spike ectodomain with bound ey6a fab |
44
|
214
|
7ps0C |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-24 fabs |
48
|
213
|
7ps1B |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-27 fab |
39
|
194
|
7ps7E |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-40 fab |
27
|
118
|
7spoC |
Crystal structure of the sars-cov-2 receptor binding domain in complex with vnar 3b4 |
24
|
110
|
7sppC |
Crystal structure of the sars-cov-2 receptor binding domain in complex with vnar 2c02 |
41
|
195
|
7sppA |
Crystal structure of the sars-cov-2 receptor binding domain in complex with vnar 2c02 |
36
|
218
|
7wueC |
Crystal structure of sars-cov-2 receptor binding domain in complex with the monoclonal antibody m31a7 |